The WHO's move to rethink the names of viral infections is entirely appropriate, the infectious disease expert notes.
Our inhaled COVID-19 vaccine would go directly to where the body needs it: the surface of the airways. This means less waste and more benefit, lower costs and reduced side-effects.
Vaccines developed at McMaster target the lungs first.
McMaster logo
McMaster logo
